Hepatic encephalopathy: current challenges and future prospects

References

• American Association for the Study of Liver DiseasesEuropean Association for the Study of the LiverHepatic Encephalopathy in Chronic Liver Disease: 2014 Practice Guideline by the European Association for the Study of the Liver and the American Association for the Study of Liver DiseasesJ Hepatol201461364265925015420
   PubMed Web of Science ®Google Scholar
• NabiEThackerLRWadeJBDiagnosis of covert hepatic encephalopathy without specialized testsClin Gastroenterol Hepatol201412813841389.e224362049
   PubMed Web of Science ®Google Scholar
• JepsenPOttPAndersenPKSorensenHTVilstrupHClinical course of alcoholic liver cirrhosis: a Danish population-based cohort studyHepatology20105151675168220186844
   PubMed Web of Science ®Google Scholar
• MokdadAALopezADShahrazSLiver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysisBMC Med201412114525242656
   PubMed Web of Science ®Google Scholar
• Public Health England. [webpage on the Internet]Deaths from Liver Disease: Implications for end of life care in England2017Accessed September 28, 2017
   Google Scholar
• PatidarKRThackerLRWadeJBCovert hepatic encephalopathy is independently associated with poor survival and increased risk of hospitalizationAm J Gastroenterol2014109111757176325178701
   PubMed Web of Science ®Google Scholar
• BajajJSSaeianKSchubertCMMinimal hepatic encephalopathy is associated with motor vehicle crashes: the reality beyond the driving testHepatology20095041175118319670416
   PubMed Web of Science ®Google Scholar
• RomanECordobaJTorrensMMinimal hepatic encephalopathy is associated with fallsAm J Gastroenterol2011106347648220978484
   PubMed Web of Science ®Google Scholar
• DharelNBajajJSDefinition and nomenclature of hepatic encephalopathyJ Clin Exp Hepatol20155Suppl 1S37S4126041955
   PubMedGoogle Scholar
• ShawcrossDJalanRThe pathophysiologic basis of hepatic encephalopathy: central role for ammonia and inflammationCell Mol Life Sci20056219-202295230416158192
   PubMed Web of Science ®Google Scholar
• DesjardinsPDuTJiangWPengLButterworthRFPathogenesis of hepatic encephalopathy and brain edema in acute liver failure: role of glutamine redefinedNeurochem Int201260769069622382077
   PubMed Web of Science ®Google Scholar
• STAHLJStudies of the blood ammonia in liver disease. Its diagnostic, prognostic, and therapeutic significanceAnn Intern Med19635812413978712
   PubMed Web of Science ®Google Scholar
• PhearEASherlockSSummerskillWHBlood-ammonium levels in liver disease and hepatic comaLancet1955268686983684014368880
   PubMed Web of Science ®Google Scholar
• OngJPAggarwalAKriegerDCorrelation between ammonia levels and the severity of hepatic encephalopathyAm J Med2003114318819312637132
   PubMed Web of Science ®Google Scholar
• KundraAJainABangaABajajGKarPEvaluation of plasma ammonia levels in patients with acute liver failure and chronic liver disease and its correlation with the severity of hepatic encephalopathy and clinical features of raised intracranial tensionClin Biochem200538869669915963970
   PubMed Web of Science ®Google Scholar
• BernalWHallCKarvellasCJAuzingerGSizerEWendonJArterial ammonia and clinical risk factors for encephalopathy and intracranial hypertension in acute liver failureHepatology20074661844185217685471
   PubMed Web of Science ®Google Scholar
• KumarRShalimarSharmaHPersistent hyperammonemia is associated with complications and poor outcomes in patients with acute liver failureClin Gastroenterol Hepatol201210892593122521861
   PubMed Web of Science ®Google Scholar
• HolecekMEvidence of a vicious cycle in glutamine synthesis and breakdown in pathogenesis of hepatic encephalopathy-therapeutic perspectivesMetab Brain Dis201429191723996300
   PubMed Web of Science ®Google Scholar
• RoseCButterworthRFZayedJManganese deposition in basal ganglia structures results from both portal-systemic shunting and liver dysfunctionGastroenterology1999117364064410464140
   PubMed Web of Science ®Google Scholar
• SpahrLButterworthRFFontaineSIncreased blood manganese in cirrhotic patients: relationship to pallidal magnetic resonance signal hyperintensity and neurological symptomsHepatology1996245111611208903385
   PubMed Web of Science ®Google Scholar
• Rivera-ManciaSRiosCMontesSManganese and ammonia interactions in the brain of cirrhotic rats: effects on brain ammonia metabolismNeurochem Res20123751074108422290316
   PubMed Web of Science ®Google Scholar
• RaiRSaraswatVADhimanRKGut microbiota: its role in hepatic encephalopathyJ Clin Exp Hepatol20155Suppl 1S29S3626041954
   PubMedGoogle Scholar
• BajajJSHylemonPBRidlonJMColonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammationAm J Physiol Gastrointest Liver Physiol20123036G675G68522821944
   PubMed Web of Science ®Google Scholar
• ZhangZZhaiHGengJLarge-scale survey of gut microbiota associated with MHE Via 16S rRNA-based pyrosequencingAm J Gastroenterol2013108101601161123877352
   PubMed Web of Science ®Google Scholar
• LiuQDuanZPHaDKBengmarkSKurtovicJRiordanSMSynbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosisHepatology20043951441144915122774
   PubMed Web of Science ®Google Scholar
• BajajJSHeumanDMHylemonPBAltered profile of human gut microbiome is associated with cirrhosis and its complicationsJ Hepatol201460594094724374295
   PubMed Web of Science ®Google Scholar
• TsaiCFChenMHWangYPProton pump inhibitors increase risk for hepatic encephalopathy in patients with cirrhosis in a population studyGastroenterology2017152113414127639806
   PubMed Web of Science ®Google Scholar
• HanaiTShirakiMWatanabeSSarcopenia predicts minimal hepatic encephalopathy in patients with liver cirrhosisHepatol Res Epub2017215
   Web of Science ®Google Scholar
• DavuluriGKrokowskiDGuanBJMetabolic adaptation of skeletal muscle to hyperammonemia drives the beneficial effects of l-leucine in cirrhosisJ Hepatol201665592993727318325
   PubMed Web of Science ®Google Scholar
• LesIDovalEGarcia-MartinezREffects of branched-chain amino acids supplementation in patients with cirrhosis and a previous episode of hepatic encephalopathy: a randomized studyAm J Gastroenterol201110661081108821326220
   PubMed Web of Science ®Google Scholar
• GluudLLDamGLesIBranched-chain amino acids for people with hepatic encephalopathyCochrane Database Syst Rev20159CD001939
   Web of Science ®Google Scholar
• QiuJThapaliyaSRunkanaAHyperammonemia in cirrhosis induces transcriptional regulation of myostatin by an NF-kappaB-mediated mechanismProc Natl Acad Sci U S A201311045181621816724145431
   PubMed Web of Science ®Google Scholar
• GuevaraMBaccaroMETorreAHyponatremia is a risk factor of hepatic encephalopathy in patients with cirrhosis: a prospective study with time-dependent analysisAm J Gastroenterol200910461382138919455124
   PubMed Web of Science ®Google Scholar
• CórdobaJGottsteinJBleiATChronic hyponatremia exacerbates ammonia-induced brain edema in rats after portacaval anastomosisJ Hepatol19982945895949824268
   PubMed Web of Science ®Google Scholar
• JalanROlde DaminkSWHayesPCDeutzNELeeAPathogenesis of intracranial hypertension in acute liver failure: inflammation, ammonia and cerebral blood flowJ Hepatol200441461362015464242
   PubMed Web of Science ®Google Scholar
• AggarwalSKramerDYonasHCerebral hemodynamic and metabolic changes in fulminant hepatic failure: a retrospective studyHepatology199419180878276371
   PubMed Web of Science ®Google Scholar
• MariniJCBroussardSRHyperammonemia increases sensitivity to LPSMol Genet Metab200688213113716497529
   PubMed Web of Science ®Google Scholar
• BaiGRama RaoKVMurthyCRPanickarKSJayakumarARNorenbergMDAmmonia induces the mitochondrial permeability transition in primary cultures of rat astrocytesJ Neurosci Res200166598199111746427
   PubMed Web of Science ®Google Scholar
• AldridgeDRTranahEJShawcrossDLPathogenesis of hepatic encephalopathy: role of ammonia and systemic inflammationJ Clin Exp Hepatol20155Suppl 1S7S2026041962
   PubMedGoogle Scholar
• FerenciPLockwoodAMullenKTarterRWeissenbornKBleiATHepatic encephalopathy–definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998Hepatology200235371672111870389
   PubMed Web of Science ®Google Scholar
• AmodioPMontagneseSGattaAMorganMYCharacteristics of minimal hepatic encephalopathyMetab Brain Dis2004193-425326715554421
   PubMed Web of Science ®Google Scholar
• WeissenbornKEnnenJCSchomerusHRuckertNHeckerHNeuropsychological characterization of hepatic encephalopathyJ Hepatol200134576877311434627
   PubMed Web of Science ®Google Scholar
• BajajJSMinimal hepatic encephalopathy matters in daily lifeWorld J Gastroenterol200814233609361518595126
   PubMed Web of Science ®Google Scholar
• BajajJSWadeJBSanyalAJSpectrum of neurocognitive impairment in cirrhosis: implications for the assessment of hepatic encephalopathyHepatology20095062014202119787808
   PubMed Web of Science ®Google Scholar
• StewartJSarkelaMKoivusaloAMFrontal electroencephalogram variables are associated with the outcome and stage of hepatic encephalopathy in acute liver failureLiver Transpl201420101256126524975240
   PubMed Web of Science ®Google Scholar
• NardoneRTaylorACHöllerYBrigoFLochnerPTrinkaEMinimal hepatic encephalopathy: A reviewNeurosci Res201611111227153746
   PubMed Web of Science ®Google Scholar
• VilstrupHAmodioPBajajJHepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the LiverHepatology201460271573525042402
   PubMed Web of Science ®Google Scholar
• RahimiRSRockeyDCOveruse of Head Computed Tomography in Cirrhosis With Altered Mental StatusAm J Med Sci2016351545946627140703
   PubMed Web of Science ®Google Scholar
• DonovanLMKressWLStrnadLCLow likelihood of intracranial hemorrhage in patients with cirrhosis and altered mental statusClin Gastroenterol Hepatol201513116516924907500
   PubMed Web of Science ®Google Scholar
• InoueEHoriSNarumiYPortal-systemic encephalopathy: presence of basal ganglia lesions with high signal intensity on MR imagesRadiology199117925515552014310
   PubMed Web of Science ®Google Scholar
• PujolAPujolJGrausFHyperintense globus pallidus on T1-weighted MRI in cirrhotic patients is associated with severity of liver failureNeurology199343165698423913
   PubMed Web of Science ®Google Scholar
• GroverVPCrosseyMMFitzpatrickJAQuantitative magnetic resonance imaging in patients with cirrhosis: a cross-sectional studyMetab Brain Dis20163161315132526251205
   PubMed Web of Science ®Google Scholar
• JiangMWangZTsauoJLiXBasal ganglia hyperintensity may be a marker of hepatic encephalopathy secondary to portosystemic shuntingClin Res Hepatol Gastroenterol2015391e5e625239699
   PubMed Web of Science ®Google Scholar
• StewartCAReivichMLuceyMRGoresGJNeuroimaging in hepatic encephalopathyClin Gastroenterol Hepatol20053319720715765437
   PubMed Web of Science ®Google Scholar
• Giménez-GarzóCGarcésJJUriosAThe PHES battery does not detect all cirrhotic patients with early neurological deficits, which are different in different patientsPLoS One2017122e017121128146589
   PubMed Web of Science ®Google Scholar
• AllampatiSDuarte-RojoAThackerLRDiagnosis of minimal hepatic encephalopathy using stroop encephalApp: a multicenter US-Based, Norm-Based StudyAm J Gastroenterol20161111788626644276
   PubMed Web of Science ®Google Scholar
• BajajJSThackerLRHeumanDMThe Stroop smartphone application is a short and valid method to screen for minimal hepatic encephalopathyHepatology20135831122113223389962
   PubMed Web of Science ®Google Scholar
• CampagnaFMontagneseSRidolaLThe animal naming test: an easy tool for the assessment of hepatic encephalopathyHepatology201766119820828271528
   PubMed Web of Science ®Google Scholar
• ArasaradnamRPMcFarlaneMLingKBreathomics–exhaled volatile organic compound analysis to detect hepatic encephalopathy: a pilot studyJ Breath Res2016101016s012
   Web of Science ®Google Scholar
• GluudLLVilstrupHMorganMYNon-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosisCochrane Database Syst Rev20165CD003044
   Web of Science ®Google Scholar
• CammaCFiorelloFTineFMarchesiniGFabbriAPagliaroLLactitol in treatment of chronic hepatic encephalopathy. A meta-analysisDig Dis Sci19933859169228482191
   PubMed Web of Science ®Google Scholar
• DhimanRKGut microbiota and hepatic encephalopathyMetab Brain Dis201328232132623463489
   PubMed Web of Science ®Google Scholar
• PohZChangPEA current review of the diagnostic and treatment strategies of hepatic encephalopathyInt J Hepatol2012201248030923133760
   PubMedGoogle Scholar
• DalalRMcGeeRGRiordanSMWebsterACProbiotics for people with hepatic encephalopathyCochrane Database Syst Rev20172CD00871628230908
   PubMed Web of Science ®Google Scholar
• Viramontes HörnerDAveryAStowRThe effects of probiotics and symbiotics on risk factors for hepatic encephalopathy: a systematic reviewJ Clin Gastroenterol201751431232328059938
   PubMed Web of Science ®Google Scholar
• MalaguarneraMGrecoFBaroneGGarganteMPToscanoMABifidobacterium longum with fructo-oligosaccharide (FOS) treatment in minimal hepatic encephalopathy: a randomized, double-blind, placebo-controlled studyDig Dis Sci200752113259326517393330
   PubMed Web of Science ®Google Scholar
• Pratap MouliVBenjaminJBhushan SinghMEffect of probiotic VSL#3 in the treatment of minimal hepatic encephalopathy: a non-inferiority randomized controlled trialHepatol Res201545888088925266207
   PubMed Web of Science ®Google Scholar
• RahimiRSSingalAGCuthbertJARockeyDCLactulose versus polyethylene glycol 3350–electrolyte solution for treatment of overt hepatic encephalopathy: the HELP randomized clinical trialJAMA Intern Med2014174111727173325243839
   PubMed Web of Science ®Google Scholar
• CrossTJLiver disease in clinical practiceSpringer International PublishingUK2017
   Google Scholar
• Atif ZamanMMPHNutritional Management of Patients with Cirrhosis and Hepatic Encephalopathy2013 Available from http://www.jwatch.org/na31703/2013/07/19/nutritional-management-patients-with-cirrhosis-and-hepaticAccessed September 28, 2017
   Google Scholar
• AmodioPBemeurCButterworthRThe nutritional management of hepatic encephalopathy in patients with cirrhosis: international society for hepatic encephalopathy and nitrogen metabolism consensusHepatology2017581325336
   Web of Science ®Google Scholar
• Chavez-TapiaNCCesar-ArceABarrientos-GutiérrezTVillegas-LópezFAMéndez-SanchezNUribeMA systematic review and meta-analysis of the use of oral zinc in the treatment of hepatic encephalopathyNutr J2013127423742732
   PubMed Web of Science ®Google Scholar
• MousaNAbdel-RazikAZaherAThe role of antioxidants and zinc in minimal hepatic encephalopathy: a randomized trialTherap Adv Gastroenterol201695684691
   Web of Science ®Google Scholar
• HawkinsRAJessyJMansAMChedidADeJosephMRNeomycin reduces the intestinal production of ammonia from glutamineAdv Exp Med Biol19943681251347741004
   PubMedGoogle Scholar
• MullenKDSanyalAJBassNMRifaximin is safe and well tolerated for long-term maintenance of remission from overt hepatic encephalopathyClin Gastroenterol Hepatol201412813901397.e224365449
   PubMed Web of Science ®Google Scholar
• PedrettiGCalzettiCMissaleGFiaccadoriFRifaximin versus neomycin on hyperammoniemia in chronic portal systemic encephalopathy of cirrhotics. A double-blind, randomized trialItal J Gastroenterol19912341751781751811
   PubMedGoogle Scholar
• SharmaBCSharmaPLuniaMKSrivastavaSGoyalRSarinSKA randomized, double-blind, controlled trial comparing rifaximin plus lactulose with lactulose alone in treatment of overt hepatic encephalopathyAm J Gastroenterol201310891458146323877348
   PubMed Web of Science ®Google Scholar
• BajajJSReview article: potential mechanisms of action of rifaximin in the management of hepatic encephalopathy and other complications of cirrhosisAliment Pharmacol Ther201643Suppl 1112626618922
   PubMed Web of Science ®Google Scholar
• BassNMMullenKDSanyalARifaximin treatment in hepatic encephalopathyN Engl J Med2010362121071108120335583
   PubMed Web of Science ®Google Scholar
• MohammadRARegalREAlanizCCombination therapy for the treatment and prevention of hepatic encephalopathyAnn Pharmacother201246111559156323092866
   PubMed Web of Science ®Google Scholar
• SidhuSSGoyalOParkerRAKishoreHSoodARifaximin versus. lactulose in treatment of minimal hepatic encephalopathyLiver Int201636337838526201713
   PubMed Web of Science ®Google Scholar
• SchulzCSchütteKKropfSRiMINI – the influence of rifaximin on minimal hepatic encephalopathy (MHE) and on the intestinal microbiome in patients with liver cirrhosis: study protocol for a randomized controlled trialTrials201617111126926775
   PubMed Web of Science ®Google Scholar
• BajajJSO’LearyJGReddyKRSecond infections independently increase mortality in hospitalized patients with cirrhosis: the North American consortium for the study of end-stage liver disease (NACSELD) experienceHepatology20125662328233522806618
   PubMed Web of Science ®Google Scholar
• LoftSSonneJDossingMAndreasenPBMetronidazole pharmacokinetics in patients with hepatic encephalopathyScand J Gastroenterol19872211171233563404
   PubMed Web of Science ®Google Scholar
• NdrahaSHasanISimadibrataMThe effect of L-ornithine L-aspartate and branch chain amino acids on encephalopathy and nutritional status in liver cirrhosis with malnutritionActa Med Indones2011431182221339541
   PubMedGoogle Scholar
• BaiMYangZQiXFanDHanGl-ornithine-l-aspartate for hepatic encephalopathy in patients with cirrhosis: a meta-analysis of randomized controlled trialsJ Gastroenterol Hepatol201328578379223425108
   PubMed Web of Science ®Google Scholar
• SortPNavasaMArroyoVEffect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitisN Engl J Med1999341640340910432325
   PubMed Web of Science ®Google Scholar
• Simon-TaleroMGarcia-MartinezRTorrensMEffects of intravenous albumin in patients with cirrhosis and episodic hepatic encephalopathy: a randomized double-blind studyJ Hepatol20135961184119223872605
   PubMed Web of Science ®Google Scholar
• RiggioONardelliSPasqualeCNo effect of albumin infusion on the prevention of hepatic encephalopathy after transjugular intrahepatic portosystemic shuntMetab Brain Dis20163161275128126290375
   PubMed Web of Science ®Google Scholar
• RockeyDCVierlingJMMantryPRandomized, double-blind, controlled study of glycerol phenylbutyrate in hepatic encephalopathyHepatology20145931073108323847109
   PubMed Web of Science ®Google Scholar
• WijdicksEFHepatic encephalopathyN Engl J Med2016375171660167027783916
   PubMed Web of Science ®Google Scholar
• LalemanWSimon-TaleroMMaleuxGEmbolization of large spontaneous portosystemic shunts for refractory hepatic encephalopathy: a multicenter survey on safety and efficacyHepatology20135762448245723401201
   PubMed Web of Science ®Google Scholar
• AnJKimKWHanSLeeJLimYSImprovement in survival associated with embolisation of spontaneous portosystemic shunt in patients with recurrent hepatic encephalopathyAliment Pharmacol Ther201439121418142624754260
   PubMed Web of Science ®Google Scholar
• EllulMAGholkarSACrossTJHepatic encephalopathy due to liver cirrhosisBMJ2015351h418726265724
   PubMed Web of Science ®Google Scholar
• HassaneinTISchadeRRHepburnISAcute-on-chronic liver failure: extracorporeal liver assist devicesCurr Opin Crit Care201117219520321346566
   PubMed Web of Science ®Google Scholar
• HassaneinTCurrent state of knowledge of hepatic encephalopathy (part IV): management of hepatic encephalopathy by liver support systemsMetab Brain Dis201732230330628013444
   PubMed Web of Science ®Google Scholar
• HassaneinTIToftengFBrownRSJrRandomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosisHepatology20074661853186217975845
   PubMed Web of Science ®Google Scholar
• BanaresRNevensFLarsenFSExtracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trialHepatology20135731153116223213075
   PubMed Web of Science ®Google Scholar
• PanthamGPostAVenkatDEinstadterDMullenKDA new look at precipitants of overt hepatic encephalopathy in cirrhosisDig Dis Sci20176282166217328560484
   PubMed Web of Science ®Google Scholar
• Romero-GomezMCordobaJJoverRValue of the critical flicker frequency in patients with minimal hepatic encephalopathyHepatology200745487988517393525
   PubMed Web of Science ®Google Scholar
• LauridsenMMThieleMKimerNVilstrupHThe continuous reaction times method for diagnosing, grading, and monitoring minimal/covert hepatic encephalopathyMetab Brain Dis201328223123423299303
   PubMed Web of Science ®Google Scholar
• AmodioPDel PiccoloFMarchettiPClinical features and survivial of cirrhotic patients with subclinical cognitive alterations detected by the number connection test and computerized psychometric testsHepatology19992961662166710347105
   PubMed Web of Science ®Google Scholar
• BajajJSHafeezullahMFrancoJInhibitory control test for the diagnosis of minimal hepatic encephalopathyGastroenterology2008135515911600.e159118723018
   PubMed Web of Science ®Google Scholar
• ZhuGQShiKQHuangSSystematic review with network meta-analysis: the comparative effectiveness and safety of interventions in patients with overt hepatic encephalopathyAliment Pharmacol Ther201541762463525684317
   PubMed Web of Science ®Google Scholar
• KeQYangRNYeFImpairment of liver regeneration by the histone deacetylase inhibitor valproic acid in miceJ Zhejiang Univ Sci B201213969570622949360
   PubMed Web of Science ®Google Scholar
• Brunetti-PierriNLanpherBErezAPhenylbutyrate therapy for maple syrup urine diseaseHum Mol Genet201120463164021098507
   PubMed Web of Science ®Google Scholar
• HolecekMVodenicarovovaMPhenylbutyrate exerts adverse effects on liver regeneration and amino acid concentrations in partially hepatectomized ratsInt J Exp Pathol201697327828427381898
   PubMed Web of Science ®Google Scholar
• Ventura-CotsMArranzJASimon-TaleroMSafety of ornithine phenylacetate in cirrhotic decompensated patients: an open-label, dose-escalating, single-cohort studyJ Clin Gastroenterol2013471088188723751856
   PubMed Web of Science ®Google Scholar
• PatidarKRBajajJSCovert and Overt Hepatic Encephalopathy: Diagnosis and ManagementClin Gastroenterol Hepatol201513122048206126164219
   PubMed Web of Science ®Google Scholar
• FerenciPHepatic encephalopathyGastroenterology Report20175213814728533911
   PubMed Web of Science ®Google Scholar